The GLP-1/GIP drug hit up to 19% mean weight loss over 48 weeks in a Chinese phase 3, with fewer GI side effects, Regeneron says. US trials are still ahead.
Recap by typeshit. Full story at AOL.
Sam Stone mixed GLP-1 Daily Support powder into a smoothie daily and came away with stomach aches and doubts about what it does.
Dr Desmond Wai shares the Novo Nordisk news and notes the FDA cleared semaglutide for fatty liver disease in the US more than a year earlier.
A short personal check-in from a creator who tags her post with tirzepatide. No numbers or details beyond the update itself.
The two actors chat about what keeps them working, how they approach fitness, and look back on Mona Singh's show Jassi Jaissi Koi Nahin.
West Midlands Police and the UK regulator raided an industrial unit and also found packaging for around 30,000 more pens.
A post hoc look at 31 GLP-1 users among 2,187 trial patients showed similar skin clearance and safety. Researchers note the small sample limits conclusions.
Loading…